IperionX Letter to Shareholders

CHARLOTTE, N.C.--(BUSINESS WIRE)-- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to release a letter to shareholders, detailing the company's breakthrough titanium technologies and business plans, as well as reflecting on a successful year in 2024 and outlining IperionX's goals for 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250206934743/en/

IperionX Virginia Operations Team (Photo: Business Wire)

During the year, IperionX achieved transformational progress, accomplishing a step change in our growth with the development of our Virginia Titanium Campus and the fast-tracked innovation activities there. IperionX is rebuilding an industry that America once led – ushering in a new era where we manufacture high-performance titanium with ground-breaking, low cost, and energy efficient technologies – right here in the United States.

A link to the full letter to shareholders can be found here.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250206934743/en/

Anastasios (Taso) Arima, Founder and CEO
Toby Symonds, President
Dominic Allen, Chief Commercial Officer

Investors: [email protected]
Media: [email protected]

+1 980 237 8900
www.iperionx.com

Source: IperionX Limited

You May Also Be Interested In

• OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
• Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual
• Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control